Shares of BeyondSpring Inc. (NASDAQ:BYSI - Get Free Report) rose 30% during trading on Monday . The company traded as high as $2.21 and last traded at $2.21. Approximately 204,049 shares traded hands during mid-day trading, an increase of 672% from the average daily volume of 26,423 shares. The stock had previously closed at $1.70.
BeyondSpring Price Performance
The company's 50-day moving average price is $1.65 and its two-hundred day moving average price is $1.66.
BeyondSpring (NASDAQ:BYSI - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported ($0.06) earnings per share for the quarter.
About BeyondSpring
(
Get Free Report)
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Recommended Stories
Before you consider BeyondSpring, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BeyondSpring wasn't on the list.
While BeyondSpring currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
